CAPITAL IMPACT ADVISORS, LLC Regeneron Pharmaceuticals, Inc. Transaction History

CAPITAL IMPACT ADVISORS, LLC portfolio value:

$308,000
portfolio value

CAPITAL IMPACT ADVISORS, LLC quarter portfolio value change:

+16.53%
quarter

Regeneron Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -11.49% -58 shares 9K $688.87 447
Q2 2022 share Decrease -59.63% -746 shares -575K $591.13 505
Q1 2022 share Decrease -35.91% -701 shares -359K $698.42 1.25K
Q4 2021 share Decrease -70.28% -4.61K shares -2.74M $642.51 1.95K
Q3 2021 share Increase +103.75% 3.34K shares 2.17M $605.18 6.56K
Q2 2021 share Increase +46.43% 1.02K shares 759K $558.54 3.22K
Q1 2021 share Decrease -46.51% -1.91K shares -947K $473.14 2.20K
Q4 2020 share 0.00% 0 shares -315K $483.11 4.11K
Q3 2020 share Decrease -26.71% -1.5K shares -1.19M $559.78 4.11K
Q2 2020 share Decrease -20.62% -1.45K shares 48K $623.65 5.61K
Q1 2020 share 0.00% 0 shares 798K $488.29 7.07K
Q4 2019 share 0.00% 0 shares 722K $375.48 7.07K
Q3 2019 share Decrease -6.70% -508 shares -421K $277.4 7.07K
Q2 2019 share 0.00% 0 shares -394K $313 7.58K
Q1 2019 share 0.00% 0 shares 0 $410.62 7.58K
Q4 2018 share 0.00% 0 shares -329K $373.5 7.58K
Q3 2018 share 0.00% 0 shares 486K $404.04 7.58K
Q2 2018 share 0.00% 0 shares -19K $344.99 7.58K
Q1 2018 share Increase +70.38% 3.13K shares 938K $344.36 7.58K
Q4 2017 share 0.00% 0 shares -317K $375.96 4.45K
Q3 2017 share Decrease -25.15% -1.49K shares -930K $447.12 4.45K
Q2 2017 share 0.00% 0 shares 616K $491.14 5.94K
Q1 2017 share Increase +57.69% 2.17K shares 920K $387.51 5.94K
Q4 2016 share 0.00% 0 shares -132K $367.09 3.77K
Q3 2016 share 0.00% 0 shares 199K $402.02 3.77K
Q2 2016 share Increase +36.10% 1K shares 319K $349.23 3.77K
Q1 2016 share Decrease -20.74% -725 shares -900K $360.44 2.77K